Citadel Advisors »

Abeona Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $553k 110k 5.01

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Abeona Therapeutics

Nantahala Capital Management
Millennium Management
Vanguard Group
Western Standard
AIGH Capital Management
Point72 Asset Management
Ikarian Capital
Citigroup
J. Goldman & Co
Worth Venture Partners
Walleye Trading Advisors
Barclays
Bank of New York Mellon
Citadel Advisors
Alyeska Investment Group

View all funds holding Abeona Therapeutics